Theriva Biologics, Inc. (TOVX) Operating cash flow 2016–2025
Theriva Biologics, Inc. (TOVX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.7MFY2025 · since FY2016: -$27.9M → -$16.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.7M | +1.6% |
| FY2024 | -$16.9M | +10.8% |
| FY2023 | -$19.0M | +0.5% |
| FY2022 | -$19.1M | -48.0% |
| FY2021 | -$12.9M | -5.9% |
| FY2020 | -$12.2M | +12.3% |
| FY2019 | -$13.9M | +19.7% |
| FY2018 | -$17.3M | +14.5% |
| FY2017 | -$20.2M | +27.6% |
| FY2016 | -$27.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice